Trans-arterial embolization of dural arteriovenous fistula using ONYX liquid embolic system. multi-center, prospective registry trial

Trans-arterial embolization of dural arteriovenous fistula using ONYX liquid embolic system. multi-center, prospective registry trial - ONYX TAE for dAVF

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000013143

Enrollment

Registered

2014-02-12

Start date

2014-02-15

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dural arteriovenous fistula

Interventions

Trans-arterial embolization of dural arteriovenous fistula using ONYX liquid embolic system

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1. modified Rankin Scale 4 or less 2. primary or recurrence of dural arteriovenous fistula 3. difficult to cure by trensvenous embolization 4. exist feeding artery suitable for ONYX embolization 5. accept documented connect form

Exclusion criteria

Exclusion criteria: 1. not indicated for intravenous heparin 2. difficult to follow-up for 6 months 3. allergy for iodine contrast 4. allergy for tantalum

Design outcomes

Primary

Measure	Time frame
curative occlusion of dural arteriovenous fistula at 6 month after embolization	—

Secondary

Measure	Time frame
1. recanalization of target lesion at 6 months after embolization 2. repeat embolization for recanalization of target lesion at 6 months after embolization 3. stroke due to recanalization of target lesion at 6 months after embolization 4. any cause of death within 6 month after embolization 5. any cause of stroke at 6 month after embolization 6. neurological deterioration at 6 month after embolization 7. modified Rankin Scale at 6 month after embolization	—

Measure

Time frame

1. recanalization of target lesion at 6 months after embolization 2. repeat embolization for recanalization of target lesion at 6 months after embolization 3. stroke due to recanalization of target lesion at 6 months after embolization 4. any cause of death within 6 month after embolization 5. any cause of stroke at 6 month after embolization 6. neurological deterioration at 6 month after embolization 7. modified Rankin Scale at 6 month after embolization

—

Countries

Japan

Contacts

Public ContactNobuyuki Sakai

Kobe City Medical Center General Hospital Neurosurgery

n.sakai@siren.ocn.ne.jp078-302-4321

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026